Showing results (1-10 of 10,517) with videos related to
Sort By:
Pageof 1,052
Journal of Medical Case Reports|January 30, 2026
Malignant glaucoma with variable outcomes after irido-zonulo-hyaloid-vitrectomy-bilateral involvement: a case reportNa Li, Yalong Dang, Fang LeiCurrent Neuropharmacology|November 12, 2025
Axonal Regeneration, Growth Cone, and the FIGN Gene Family: A Comprehensive ReviewNa Li, Haoliang Chen, Yalong Dang, et al.Clinical Case Reports|January 26, 2026
A Novel N-Terminal PRPF6 Variant in Autosomal Dominant Retinitis PigmentosaNa Li, Yalong DangClinical Case Reports|December 29, 2025
Atypical Retinitis Pigmentosa With Macular Sparing in a Patient With Compound Heterozygous ABCA4 Variants: A Case Report and Diagnostic ChallengeNa Li, Yalong DangDrug Design, Development and Therapy|May 12, 2026
Effect of Rho Kinase Inhibitor RKI-1447 on Dexamethasone-Induced Ocular Hypertension and Its Molecular Mechanisms in Sprague-Dawley RatsJunhui Wu, Yalong Dang, Fang LeiCurrent Eye Research|May 7, 2026
Topical CAY-10746, a Novel ROCK Inhibitor, Reduces Intraocular Pressure and Modulates the Trabecular Meshwork in Normotensive RatsMenglong Hao, Yalong Dang, Fang LeiCurrent Medicinal Chemistry|February 11, 2025
A Scoping Review of Rho Kinase Inhibitors and their Role in Glaucoma TreatmentMenglong Hao, Yalong Dang, Fang LeiCurrent Eye Research|August 11, 2025
Transcriptome Sequencing Reveals ceRNA Networks and Molecular Signatures in Myopic Mouse RetinaXueting Wang, Huiman Zhuang, Yalong Dang, et al.Frontiers in Immunology|October 3, 2025
Circular RNAs and immunotherapy in retinoblastoma: emerging biomarkers and precision therapeutic strategiesXueting Wang, Jiakang Ma, Yalong Dang, et al.Current Drug Targets|December 29, 2023
Rho Kinase (ROCK) Inhibitors for the Treatment of GlaucomaJunhui Wu, Jing Wei, Haoliang Chen, et al.Pageof 1,052